Using a Modified Delphi Panel to Estimate Health Service Utilization for Patients with Advanced and Non-Advanced Systemic Light Chain Amyloidosis.
Morie GertzRafat AbonourSarah N GibbsMuriel FinkelHeather LandauSuzanne LentzschGrace LinAnuj MahindraTiffany QuockCara RosenbaumMichael RosenzweigSurbhi SidanaSascha A TuchmanRonald WittelesIrina YermilovMichael S BroderPublished in: ClinicoEconomics and outcomes research : CEOR (2023)
Experts estimated advanced patients, who would not be good candidates for HSCT, would have high rates of hospitalization (traditionally the most expensive type of healthcare utilization) and other health service use. The development of new treatment options that can facilitate organ recovery and improve function may lead to decreased utilization.
Keyphrases